|本期目录/Table of Contents|

[1]张嘉琦,贾佩琦,苏东明.染色盒同源物3对人结直肠癌细胞增殖的影响及其机制研究[J].医学研究与战创伤救治(原医学研究生学报),2021,23(01):6-11.[doi:10.3969/j.issn.1672-271X.2021.01.001]
　ZHANG Jia-qi,JIA Pei-qi,SU Dong-ming.The effect of CBX3 on the biological behavior of human colorectal cancer cells and its mechanism[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(01):6-11.[doi:10.3969/j.issn.1672-271X.2021.01.001]
点击复制

染色盒同源物3对人结直肠癌细胞增殖的影响及其机制研究()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第23卷
期数:
2021年01期
页码:
6-11
栏目:
基础研究
出版日期:
2021-01-20

文章信息/Info

Title:
The effect of CBX3 on the biological behavior of human colorectal cancer cells and its mechanism
作者:
张嘉琦; 贾佩琦; 苏东明
作者单位：211166南京，南京医科大学病理学系（张嘉琦、贾佩琦、苏东明）
Author(s):
ZHANG Jia-qi; JIA Pei-qi; SU Dong-ming
(Department of Pathology, Nanjing Medical University, Nanjing 211166, Jiangsu, China)
关键词:
结直肠癌; 染色盒同源物3; 增殖; CCAAT/增强子结合蛋白delta
Keywords:
colorectal cancer;  chromebox3;  proliferation;  CCAAT/enhancer-binding protein delta
分类号:
R36
DOI:
10.3969/j.issn.1672-271X.2021.01.001
文献标志码:
A
摘要:
目的探讨染色盒同源物3（CBX3）在结直肠癌组织和细胞中的表达，及其对结直肠癌细胞增殖能力的影响，并初步探讨其机制。方法运用生物信息学方法对CBX3的表达情况、生存期以及共表达网络进行分析。应用免疫组织化学染色法检测CBX3在结直肠癌组织和配对癌旁组织中的差异表达。应用Western blot检测正常结肠上皮细胞NCM460以及结直肠癌细胞HCT116、HT29、SW620中CBX3的表达水平。将CBX3过表达质粒和特异性小干扰分别转染至HCT116细胞中，采用磺酰罗丹明B（SRB）染色实验和克隆形成实验检测细胞的增殖能力。应用转录组测序技术检测差异表达基因。应用qRT-PCR及Western blot实验对差异基因进行验证。应用生物信息学方法对差异基因及CBX3进行相关性分析。结果生物信息学分析显示CBX3在结直肠癌组织中表达高于癌旁组织（P<0.001），CBX3高表达组患者无病生存期低于低表达组（P<0.05），CBX3对转录组的影响广泛且复杂。CBX3在结直肠癌组织中表达高于配对癌旁组织（P<0.0001）。CBX3在结直肠癌细胞中表达高于正常结肠上皮细胞（P<0.01）。SRB实验及克隆形成实验证实，过表达CBX3增强了HCT116细胞的增殖能力，敲低CBX3增殖能力降低（P<0.01）。转录组测序结果显示，敲低CBX3后，CCAAT/增强子结合蛋白delta（CEBPD）mRNA表达升高（P<0.001），蛋白表达相应升高（P<0.05），且两者存在负性相关（P<0.001，R=-0.2）。结论CBX3在结直肠癌组织及细胞中高表达，能够在体外促进细胞增殖。CBX3可能通过抑制CEBPD转录因子的表达来发挥促癌作用。
Abstract:
ObjectiveTo investigate the expression of Chromebox3 (CBX3) in colorectal cancer tissues and cells. To explore the effect of CBX3 on the proliferation ability of colorectal cancer cells and its mechanism.MethodsThe bioinformatics method was used to analyze the expression, survival time and co-expression network of CBX3. Immunohistochemical staining was used to detect the differential expression of CBX3 in colorectal cancer tissues and paired adjacent tissues. Western blot was used to detect the expression level of CBX3 in normal colon epithelial cells NCM460 and colorectal cancer cells HCT116, HT29 and SW620. The CBX3 expression plasmid and specific siRNA were transfected into HCT116 cells, respectively. Sulfhodamine B (SRB) staining experiment and clone formation experiment were used to detect the cell proliferation ability. RNA-seq was used to detect differentially expressed genes. qRT-PCR and Western blot were used to verify the differential genes. Bioinformatics method was used to analyze the correlation between differential genes and CBX3.ResultsBioinformatics analysis showed that the expression of CBX3 in colorectal cancer tissues was higher than that in adjacent tissues (P<0.001). The disease-free survival time of patients with high expression of CBX3 was lowerthan that of patients with low expression of CBX3 (P<0.05). CBX3 had extensive and complex effects on the transcriptome. The expression of CBX3 in colorectal cancer tissues was higher than that in matched adjacent tissues (P<0.0001). The expression of CBX3 in colorectal cancer cells was higher than that in normal colon epithelial cells (P<0.01). SRB experiment and clone formation experiment confirmed that overexpression of CBX3 enhanced the proliferation of HCT116 cells, while knockdown of CBX3 decreased the proliferation of HCT116 cells (P<0.01). Transcriptome sequencing results showed that the mRNA expression of CCAAT / enhancer binding protein Delta (CEBPD) was increased after knocking down of CBX3 (P<0.001), and the protein expression was correspondingly increased (P<0.05), and there was a negative correlation between CEBPD and CBX3 (P<0.001, R=-0.2).ConclusionCBX3 is highly expressed in colorectal cancer tissues and cells, and can promote cell proliferation in vitro. CBX3 may play a role in promoting tumor progression by inhibiting the expression of CEBPD transcription factors.

参考文献/References:

[1]Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer[J]. Lancet, 2019,394(10207):1467-1480.
[2]陈昕涛,姚厚山.结直肠癌腹腔镜手术治疗的研究进展[J].东南国防医药,2020,22(3):283-288.
[3]杨蓉蓉,徐兴国,黄新冲.全麻联合硬膜外阻滞与腹横肌平面阻滞对结直肠癌根治术患者术后恢复的影响[J].医学研究生学报,2019,32(10):1070-1075.
[4]Jiao S, Peters U, Berndt S, et al. Estimating the heritability of colorectal cancer[J]. Hum Mol Genet, 2014,23(14):3898-3905.
[5]Liu M, Huang F, Zhang D, et al. Heterochromatin protein HP1γ promotes colorectal cancer progression and is regulated by miR-30a[J]. Cancer Res, 2015,75(21):4593-4604.
[6]Bártová E, Malyková B, Komu。rková D, et al. Function of heterochromatin protein 1 during DNA repair[J]. Protoplasma, 2017,254(3):1233-1240.
[7]Kwon SH, Workman JL. The changing faces of HP1: From heterochromatin formation and gene silencing to euchromatic gene expression: HP1 acts as a positive regulator of transcription[J]. Bioessays， 2011，33(4):280-289.
[8]Yearim A, Gelfman S, Shayevitch R, et al. HP1 is involved in regulating the global impact of DNA methylation on alternative splicing[J]. Cell Rep, 2015,10(7):1122-1134.
[9]Mattout A, Aaronson Y, Sailaja BS, et al. Heterochromatin Protein 1β (HP1β) has distinct functions and distinct nuclear distribution in pluripotent versus differentiated cells[J]. Genome Biol, 2015，16:213.
[10]Casale AM, Cappucci U, Fanti L, et al. Heterochromatin protein 1 (HP1)is intrinsically required for post-transcriptional regulation of Drosophila Germline Stem Cell (GSC) maintenance[J]. Sci Rep, 2019,9(1):4372.
[11]Chakraborty A, Prasanth SG. Phosphorylation-dephosphorylation cycle of HP1α governs accurate mitotic progression[J]. Cell Cycle, 2014,13(11):1663-1670.
[12]Canzio D, Larson A, Narlikar GJ. Mechanisms of functional promiscuity by HP1 proteins[J]. Trends Cell Biol, 2014,24(6):377-386.
[13]Alam H, Li N, Dhar SS, et al. HP1γ Promotes Lung Adenocarcinoma by Downregulating the Transcription-Repressive Regulators NCOR2 and ZBTB7A[J]. Cancer Res, 2018,78(14):3834-3848.
[14]Chen LY, Cheng CS, Qu C, et al. Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression[J]. Int J Mol Sci, 2018,19(6):1768.
[15]Yu YJ, Xu YY, Lan XO, et al. Shikonin induces apoptosis and suppresses growth in keratinocytes via CEBP-δ upregulation[J]. Int Immunopharmacol, 2019,72:511-521.
[16]Ma C, Nie XG, Wang YL, et al. CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma[J]. Mol Med Rep, 2019,19(5):4205-4212.

相似文献/References:

[1]李丙军,丁江华,洪建明.卡培他滨节拍化疗治疗转移性结直肠癌22例[J].医学研究与战创伤救治(原医学研究生学报),2010,12(03):247.
[2]王莉娜,高 静.西妥昔单抗致甲沟炎的护理体会[J].医学研究与战创伤救治(原医学研究生学报),2010,12(04):354.
[3]陈昌浩,孙岳军,王建东.受体酪氨酸激酶EphB6蛋白在结直肠癌中表达及临床意义[J].医学研究与战创伤救治(原医学研究生学报),2016,18(04):346.[doi:10.3969/j.issn.1672-271X.2016.04.003]
　CHEN Chang-hao,SUN Yue-jun,WANG Jian-dong..Clinical significance of decreased expression of EphB6 receptor tyrosine kinase in colorectal carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(01):346.[doi:10.3969/j.issn.1672-271X.2016.04.003]
[4]陈昕涛,高倩闽,李明明综述,等.个体化用药方案在结直肠癌患者化疗中的临床应用进展[J].医学研究与战创伤救治(原医学研究生学报),2020,22(01):65.[doi:10.3969/j.issn.1672-271X.2020.01.015]
　CHENXin-tao,GAO Qian-min,LI Ming-ming reviewing,et al.Progress in clinical application of individualized drugs in the treatment of colorectal cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(01):65.[doi:10.3969/j.issn.1672-271X.2020.01.015]
[5]陈昕涛综述,姚厚山审校.结直肠癌腹腔镜手术治疗的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2020,22(3):283.[doi:10.3969/j.issn.1672-271X.2020.03.013]
　CHEN Xin-tao reviewing,YAO Hou-shan checking.Progress of laparoscopic surgery for colorectal cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(01):283.[doi:10.3969/j.issn.1672-271X.2020.03.013]

备注/Memo

备注/Memo:
基金项目：国家自然科学基金（81570779）
更新日期/Last Update: 2021-01-26